This observational study will serve to collect data from medical record and review questionnaires before and after focal ablation of prostate tissue. All enrolled subjects will have already undergone or scheduled to receive the focal therapy as part of their prostate cancer treatment.
Age
18–any
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Subject has elected or already undergone focal therapy as their standard of care treatment method and declined alternative treatment (active surveillance, radical prostatectomy, and radiation therapy)
PSA ≤ 20
Ability to complete informed consent form
You may not be if
Contraindication to follow-up multi parametric MRI or prostate biopsy
Unable to tolerate general or regional anesthesia
Clareo Health | Focal Therapy for Localized Prostate Cancer
